April 19, 2024
A blood thinner, diabetes treatments and drugs used to treat autoimmune disease and heart failure are on the list of 10 drugs targeted for price negotiations to cut Medicare costs.

A blood thinner, diabetes treatments and drugs used to treat autoimmune disease and heart failure are on the list of 10 drugs that the Centers for Medicare & Medicaid Services has targeted for price negotiations to cut Medicare costs.

In a statement, the government said the list of 10 drugs represented more than $50 billion, or about 20%, of Part D gross covered prescription drug costs between June 1, 2022 and May 31, 2023. That’s the period used to decide which drugs were eligible for negotiation.

RELATED: Biden targets diabetes drug Jardiance, blood thinner Eliquis and 8 others for Medicare price talks

The next step is for the government to negotiate prices for the 10 drugs with their manufacturers, in an effort to reduce prices for patients. The program already faces lawsuits from drugmakers and criticism from Republican lawmakers. It’s also a centerpiece of Demcrat Joe Biden’s reelection pitch as he seeks a second term in office by touting his work to lower costs for Americans at a time when the country has struggled with inflation.

The selected drugs for the first round of negotiation are:

Eliquis – blood thinner
Jardiance – type 2 diabetes medication
Xarelto – blood thinner
Januvia – type 2 diabetes medication
Farxiga – type 2 diabetes medication
Entresto – heart failure medication
Enbrel – autoimmune disease medication
Imbruvica – cancer medication
Stelara – Crohn’s disease medication
Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill – type 1 diabetes medication

The Centers for Medicare & Medicaid Services will publish any agreed-upon negotiated prices for the selected drugs by September 1, 2024 and the new pricing will take effect in January 1, 2026. In future years, CMS will select for negotiation up to 15 more drugs covered under Part D for 2027, up to 15 more drugs for 2028 (including drugs covered under Part B and Part D), and up to 20 more drugs for each year after that, as outlined in the Inflation Reduction Act.

The Associated Press contributed to this report

Related Articles

Health |


Biden targets diabetes drug Jardiance, blood thinner Eliquis and 8 others for Medicare price talks

Health |


She secretly funds psychedelic trips for Bay Area firefighters. Is this the future of mental health treatment?

Health |


Opinion: A good death on hospice for my mom after brain cancer horror

Health |


When does a heart murmur need treatment?

Health |


A California woman needed a kidney. New Kids on the Block helped find one

>